Protocols for Lung Cancer
| HIC 0809004248 Scott Gettinger M.D. Sorafenib Long Term Extension Program (STEP) |
| HIC 0708002987 Scott Gettinger M.D. A Phase I/II Trial of Induction Carboplatin/Paclitaxel with Bevacizumab Followed by Concurrent Thoracic Conformal Radiation Therapy with Carboplatin/ Paclitaxel, Bevacizumab and Erlotinib in Stage III A/B Non-small Cell Lung Cancer |
| HIC 0811004507 Roy Decker M.D., PhD A Dose Escalation Study of Vorinostat in Combination with Palliative Radiotherapy for Patients with Non-Small Cell Lung Cancer |
| HIC 0707002901 Scott Gettinger M.D. Phase I/II Trial of Induction Carboplatin/Paclitaxel with Bevacizumab followed by Concurrent Thoracic Conformal Radiation Therapy with Carboplatin/ Paclitaxel, Bevacizumab and Erlotinib in Stage III A/B Non-small Cell Lung Cancer |
| HIC 0904005074 Scott Gettinger M.D. (ECOG 1505) A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (greater than or equal to 4 cm)-IIIA Non-Small Cell Lung Cancer (NSCLC) |
| HIC 0805003786 Scott Gettinger M.D. A Phase 1/2 Study of XL184 with or without Erlotinib in Subjects with Non-Small Cell Lung Cancer |